VG Life Sciences Company Description
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.
It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation.
The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers.
In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases.
VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012.
The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. is a subsidiary of KH Feelux Co., Ltd.
| Country | United States |
| Founded | 1995 |
| Industry | Real Estate - Development |
| Sector | Real Estate |
| Employees | 1 |
| CEO | Haig Keledjian |
Contact Details
Address: 121 Gray Avenue Santa Barbara, Delaware 93101 United States | |
| Phone | 805 879 9000 |
| Website | vglifesciences.com |
Stock Details
| Ticker Symbol | VGLS |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US91822T1016 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Haig Keledjian | Co-Founder, Chairman, Chief Executive Officer, President, Vice President of Research and Development, Chief Financial Officer and Secretary |
| Dr. M. Karen Newell-Rogers | Chief Scientist |
| Robert A. Forrester | Corporate Counsel |
| Robert Berliner B.Sc., J.D. | Consultant and Advisory Board Member |